Foreign-Trade Zone (FTZ) 7-Mayaguez, Puerto Rico; Notification of Proposed Production Activity; Neolpharma, Inc. (Pharmaceutical Products); Caguas, Puerto Rico, 48726-48727 [2014-19542]

Download as PDF 48726 Federal Register / Vol. 79, No. 159 / Monday, August 18, 2014 / Notices DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B–56–2014] mstockstill on DSK4VPTVN1PROD with NOTICES Foreign-Trade Zone 49—Newark/ Elizabeth, New Jersey; Application for Reorganization and Expansion Under Alternative Site Framework An application has been submitted to the Foreign-Trade Zones (FTZ) Board by The Port Authority of New York and New Jersey, grantee of FTZ 49, requesting authority to reorganize and expand the zone under the alternative site framework (ASF) adopted by the FTZ Board (15 CFR 400.2(c)). The ASF is an option for grantees for the establishment or reorganization of zones and can permit significantly greater flexibility in the designation of new subzones or ‘‘usage-driven’’ FTZ sites for operators/users located within a grantee’s ‘‘service area’’ in the context of the FTZ Board’s standard 2,000-acre activation limit for a zone. The application was submitted pursuant to the Foreign-Trade Zones Act, as amended (19 U.S.C. 81a–81u), and the regulations of the Board (15 CFR part 400). It was formally docketed on August 11, 2014. FTZ 49 was approved by the Board on April 6, 1979 (Board Order 146, 44 FR 22502, 4/16/79) and expanded on May 26, 1983 (Board Order 211, 48 FR 24958, 6/3/83), on October 23, 1987 (Board Order 365, 52 FR 41599, 10/29/87), on April 19, 1990 (Board Order 470, 55 FR 17478, 4/25/90), on December 15, 1999 (Board Order 1067, 64 FR 72462–72643, 12/28/99), on April 14, 2006 (Board Order 1446, 71 FR 23895, 4/25/06), on February 28, 2007 (Board Order 1504, 72 FR 10642–10643, 3/9/07), on July 16, 2009 (Board Order 1634, 74 FR 37688– 37689, 7/29/09) and on February 6, 2013 (Board Order 1884, 78 FR 12716, 2/25/ 13). The current zone includes the following sites in the Newark/Elizabeth area: Site 1 (total—2,075 acres, sunset 2/ 28/18)—Port Newark/Elizabeth Port Authority Marine Terminal (2,029 acres), a parcel (23 acres) located at 888 Doremus Avenue, Newark, a parcel (6 acres) located at 580 Division Street, Elizabeth, and a parcel (17 acres) located at 251–259 Kapowski Road, Elizabeth; Site 2 (64 acres, sunset 2/28/ 18)—Global Terminal and Container Services facility (41 acres) and adjacent Jersey Distribution Services facility (23 acres) Jersey City/Bayonne; Site 3 (124 acres, sunset 2/28/18)—Port Authority Industrial Park, adjacent to the Port Newark/Elizabeth Port Authority Marine Terminal; Site 4 (198 acres, VerDate Mar<15>2010 16:57 Aug 15, 2014 Jkt 232001 sunset 2/28/18)—Port Authority Auto Marine Terminal (145 acres) and adjacent 53-acre Greenville Industrial Park on Upper New York Bay’s Port Jersey Channel in Bayonne and Jersey City; Site 5 (40 acres, sunset 2/28/18)— Newark International Airport jet fuel storage and distribution system in the Cities of Newark and Elizabeth (Essex and Union Counties); Site 6 (407 acres, sunset 2/28/18)—within an industrial park located at 100 Central Avenue, Kearny; Site 13 (546 acres, sunset 2/28/ 18)—Raritan Center Business Park, 300 Raritan Center, Edison; Temporary Site 14 (2 acres, expires 9/30/15)—National Retail Transportation, Inc., 2700 16th Street, North Bergen; and, Temporary Site 15 (16 acres, expires 1/31/15)— Western Carriers, Inc., 2400 83rd Street and 8501 West Side Avenue, N. Bergen. (Note: Sites 7 through 10 sunsetted on 3/31/14. Sites 11 and 12 sunsetted on 7/ 31/14.) The grantee’s proposed service area under the ASF would be the County of Hudson, New Jersey, in its entirety, as well as those parts of the Counties of Bergen, Essex, Passaic, Union, Middlesex, Monmouth, Morris and Somerset, New Jersey, which lie within the Port Authority’s jurisdiction known as the Port District, as described in the application. If approved, the grantee would be able to serve sites throughout the service area based on companies’ needs for FTZ designation. The proposed service area is within and adjacent to the Newark/Elizabeth Customs and Border Protection port of entry. The applicant is requesting authority to reorganize and expand its existing zone to include existing Sites 1, 2, 3, 4, 6 and 13 as magnet sites and existing Site 5 and temporary Sites 14 and 15 as usage-driven sites. The ASF allows for the possible exemption of one magnet site from the ‘‘sunset’’ time limits that generally apply to sites under the ASF, and the applicant proposes that Site 1 be so exempted. The application would have no impact on FTZ 49’s previously authorized subzones. In accordance with the FTZ Board’s regulations, Kathleen Boyce of the FTZ Staff is designated examiner to evaluate and analyze the facts and information presented in the application and case record and to report findings and recommendations to the FTZ Board. Public comment is invited from interested parties. Submissions shall be addressed to the FTZ Board’s Executive Secretary at the address below. The closing period for their receipt is October 17, 2014. Rebuttal comments in response to material submitted during the foregoing period may be submitted PO 00000 Frm 00007 Fmt 4703 Sfmt 4703 during the subsequent 15-day period to November 3, 2014. A copy of the application will be available for public inspection at the Office of the Executive Secretary, Foreign-Trade Zones Board, Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., Washington, DC 20230–0002, and in the ‘‘Reading Room’’ section of the FTZ Board’s Web site, which is accessible via www.trade.gov/ftz. For further information, contact Kathleen Boyce at Kathleen.Boyce@trade.gov or (202) 482– 1346. Dated: August 12, 2014. Andrew McGilvray, Executive Secretary. [FR Doc. 2014–19541 Filed 8–15–14; 8:45 am] BILLING CODE 3510–DS–P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B–58–2014] Foreign-Trade Zone (FTZ) 7— Mayaguez, Puerto Rico; Notification of Proposed Production Activity; Neolpharma, Inc. (Pharmaceutical Products); Caguas, Puerto Rico The Puerto Rico Industrial Development Company, grantee of FTZ 7, submitted a notification of proposed production activity to the FTZ Board on behalf of Neolpharma, Inc. (Neolpharma), located in Caguas, Puerto Rico. The notification conforming to the requirements of the regulations of the FTZ Board (15 CFR 400.22) was received on August 12, 2014. A separate application for subzone designation at the Neolpharma facility was submitted and is being processed under Section 400.31 of the FTZ Board’s regulations. The facility is used for the production of pharmaceutical products. Pursuant to 15 CFR 400.14(b), FTZ activity would be limited to the specific foreign-status materials and components and specific finished products described in the submitted notification (as described below) and subsequently authorized by the FTZ Board. Production under FTZ procedures could exempt Neolpharma from customs duty payments on the foreign status components used in export production. On its domestic sales, Neolpharma would be able to choose the duty rates during customs entry procedures that apply to the finished products: Clarithromycin, azithromycin, levothyroxine, hydroxyzine pamoate and, hydroxyzine hydrochloride (duty free) for the foreign-status inputs noted E:\FR\FM\18AUN1.SGM 18AUN1 Federal Register / Vol. 79, No. 159 / Monday, August 18, 2014 / Notices below. Customs duties also could possibly be deferred or reduced on foreign status production equipment. The components and materials sourced from abroad include sodium alginate and the following active pharmaceutical ingredients: Clarithromycin, azithromycin monohydrate, levothyroxine sodium, and hydroxyzine pamoate (duty rate ranges from free to 6.5%). Public comment is invited from interested parties. Submissions shall be addressed to the FTZ Board’s Executive Secretary at the address below. The closing period for their receipt is September 29, 2014. A copy of the notification will be available for public inspection at the Office of the Executive Secretary, Foreign-Trade Zones Board, Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., Washington, DC 20230–0002, and in the ‘‘Reading Room’’ section of the FTZ Board’s Web site, which is accessible via www.trade.gov/ftz. For further information, contact Diane Finver at Diane.Finver@trade.gov or (202) 482–1367. Dated: August 12, 2014. Andrew McGilvray, Executive Secretary. [FR Doc. 2014–19542 Filed 8–15–14; 8:45 am] BILLING CODE 3510–DS–P DEPARTMENT OF COMMERCE International Trade Administration [A–570–890] Wooden Bedroom Furniture From the People’s Republic of China: Preliminary Results of Changed Circumstances Review, and Intent To Revoke Antidumping Duty Order in Part Enforcement and Compliance, International Trade Administration, Department of Commerce. SUMMARY: On March 12, 2014, the Department of Commerce (the ‘‘Department’’) received a request for revocation, in part, of the antidumping duty (‘‘AD’’) order on wooden bedroom furniture from the People’s Republic of China (‘‘PRC’’) 1 with respect to certain wall bed units. We preliminarily determine that the producers accounting for substantially all of the production of the domestic like product to which the mstockstill on DSK4VPTVN1PROD with NOTICES AGENCY: 1 See Notice of Amended Final Determination of Sales at Less Than Fair Value and Antidumping Duty Order: Wooden Bedroom Furniture From the People’s Republic of China, 70 FR 329 (January 4, 2005) (‘‘Order’’). VerDate Mar<15>2010 16:57 Aug 15, 2014 Jkt 232001 Order pertains lack interest in the relief provided by the Order with respect to certain wall bed units described below. Accordingly, we intend to revoke, in part, the Order as to imports of certain wall bed units. The Department invites interested parties to comment on these preliminary results. DATES: Effective Date: August 18, 2014. FOR FURTHER INFORMATION CONTACT: Erin Kearney or Howard Smith, AD/CVD Operations, Office IV, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce, 14th Street and Constitution Avenue NW., Washington, DC 20230; telephone: (202) 482–0167 or (202) 482– 5193, respectively. Background On January 4, 2005, the Department published the Order in the Federal Register. On March 12, 2014, the Department received a request on behalf of Techcraft Manufacturing, Inc. (‘‘Techcraft’’) for a changed circumstances review to revoke, in part, the Order with respect to certain wall bed units.2 In its request, Techcraft stated that the American Furniture Manufacturing Committee for Legal Trade and Vaughan-Basset Furniture Company, Inc. (‘‘Petitioners’’) discussed the scope exclusion described below and are in agreement with the revocation, in part. On March 19, 2014, the Department received a letter from the Petitioners in which they stated they were in agreement with the proposed scope exclusion language in Techcraft’s March 12, 2014 changed circumstances review request.3 On May 2, 2014, we published the Initiation Notice in the Federal Register. Because the statement submitted by Petitioners in support of Techcraft’s Request did not indicate whether Petitioners account for substantially all of the domestic wooden bedroom furniture production, in the Initiation Notice, we invited interested parties to submit comments concerning industry support, as well as comments and/or factual information regarding the changed circumstances review. On May 14, 2014, Petitioners submitted comments stating that they are not aware of any U.S. domestic producer that opposes exclusion of the merchandise defined in Techcraft’s Request, and that if no interested party raises an objection to the exclusion, the 2 See Submission from Techcraft, ‘‘Techcraft Manufacturing Inc. Request for a Changed Circumstance Review,’’ dated March 12, 2014 (‘‘Techcraft’s Request’’). 3 See Submission from Petitioners, ‘‘Petitioners’ Response to Techcraft’s Letter of March 12, 2014,’’ dated March 19, 2014. PO 00000 Frm 00008 Fmt 4703 Sfmt 4703 48727 Department should issue a determination excluding certain wall bed units, as defined in Techcraft’s Request. On May 16, 2014, Techcraft submitted comments stating that the record of the proceeding demonstrates that there is no longer interest in having wall bed units that meet the scope exclusion language provided in the Initiation Notice covered by the Order. On June 13, 2014 and July 1, 2014, Techcraft revised the proposed scope exclusion language in its original changed circumstances review request.4 On July 9, 2014, the Department received a letter from the Petitioners in which they consented to the revised scope exclusion language contained in Techcraft’s July 1, 2014, submission.5 Scope of the Order The product covered by the order is wooden bedroom furniture. Wooden bedroom furniture is generally, but not exclusively, designed, manufactured, and offered for sale in coordinated groups, or bedrooms, in which all of the individual pieces are of approximately the same style and approximately the same material and/or finish. The subject merchandise is made substantially of wood products, including both solid wood and also engineered wood products made from wood particles, fibers, or other wooden materials such as plywood, strand board, particle board, and fiberboard, with or without wood veneers, wood overlays, or laminates, with or without non-wood components or trim such as metal, marble, leather, glass, plastic, or other resins, and whether or not assembled, completed, or finished. The subject merchandise includes the following items: (1) Wooden beds such as loft beds, bunk beds, and other beds; (2) wooden headboards for beds (whether stand-alone or attached to side rails), wooden footboards for beds, wooden side rails for beds, and wooden canopies for beds; (3) night tables, night stands, dressers, commodes, bureaus, mule chests, gentlemen’s chests, bachelor’s chests, lingerie chests, wardrobes, vanities, chessers, chifforobes, and wardrobe-type cabinets; (4) dressers with framed glass mirrors that are attached to, incorporated in, sit on, or hang over the dresser; (5) chests4 See Submissions from Techcraft, ‘‘Techcraft Manufacturing Inc., Request for a Changed Circumstance Review,’’ dated June 13, 2014; ‘‘Techcraft Manufacturing Inc. Request for Amended Language in Changed Circumstance Review,’’ dated July 1, 2014. 5 See Submission from Petitioners, ‘‘Petitioners’ Response to Techcraft’s Letter Filed on July 1, 2014,’’ dated July 9, 2014. E:\FR\FM\18AUN1.SGM 18AUN1

Agencies

[Federal Register Volume 79, Number 159 (Monday, August 18, 2014)]
[Notices]
[Pages 48726-48727]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-19542]


-----------------------------------------------------------------------

 DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-58-2014]


Foreign-Trade Zone (FTZ) 7--Mayaguez, Puerto Rico; Notification 
of Proposed Production Activity; Neolpharma, Inc. (Pharmaceutical 
Products); Caguas, Puerto Rico

    The Puerto Rico Industrial Development Company, grantee of FTZ 7, 
submitted a notification of proposed production activity to the FTZ 
Board on behalf of Neolpharma, Inc. (Neolpharma), located in Caguas, 
Puerto Rico. The notification conforming to the requirements of the 
regulations of the FTZ Board (15 CFR 400.22) was received on August 12, 
2014.
    A separate application for subzone designation at the Neolpharma 
facility was submitted and is being processed under Section 400.31 of 
the FTZ Board's regulations. The facility is used for the production of 
pharmaceutical products. Pursuant to 15 CFR 400.14(b), FTZ activity 
would be limited to the specific foreign-status materials and 
components and specific finished products described in the submitted 
notification (as described below) and subsequently authorized by the 
FTZ Board.
    Production under FTZ procedures could exempt Neolpharma from 
customs duty payments on the foreign status components used in export 
production. On its domestic sales, Neolpharma would be able to choose 
the duty rates during customs entry procedures that apply to the 
finished products: Clarithromycin, azithromycin, levothyroxine, 
hydroxyzine pamoate and, hydroxyzine hydrochloride (duty free) for the 
foreign-status inputs noted

[[Page 48727]]

below. Customs duties also could possibly be deferred or reduced on 
foreign status production equipment.
    The components and materials sourced from abroad include sodium 
alginate and the following active pharmaceutical ingredients: 
Clarithromycin, azithromycin monohydrate, levothyroxine sodium, and 
hydroxyzine pamoate (duty rate ranges from free to 6.5%).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the FTZ Board's Executive Secretary at the 
address below. The closing period for their receipt is September 29, 
2014.
    A copy of the notification will be available for public inspection 
at the Office of the Executive Secretary, Foreign-Trade Zones Board, 
Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., 
Washington, DC 20230-0002, and in the ``Reading Room'' section of the 
FTZ Board's Web site, which is accessible via www.trade.gov/ftz.
    For further information, contact Diane Finver at 
Diane.Finver@trade.gov or (202) 482-1367.

    Dated: August 12, 2014.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2014-19542 Filed 8-15-14; 8:45 am]
BILLING CODE 3510-DS-P